<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>22</id><JournalTitle>INHIBITORS AND BLOCKERS OF RENIN-ANGIOTENSIN SYSTEM IN THE PREVENTION AND IN DELAYING THE PROGRESSION OF DIABETIC NEPHROPATHY â€“ A COMPARATIVE STUDY</JournalTitle><Abstract>Diabetic nephropathy is the leading cause of End Stage Renal Disease (ESRD) worldwide. Angiotensin Converting
Enzyme Inhibitors (ACEI), Angiotensin Receptor Blockers (ARB) are currently employed antihypertensives in the prevention of
diabetic nephropathy. This study was done to evaluate & to compare the efficacy, safety and phamacoeconomics of the
antihypertensives, ACEI and ARB in the prevention as well as in delaying the progression of diabetic nephropathy. A total of
108 diabetic nephropathy patients with mean age group of 57.26Â± 9.77 years were selected for the study after obtaining informed
consent. They were divided into 2 groups, ACEI group and ARB group. Patient history interview was done. The Laboratory data
such as Serum Creatinine, estimated Glomerular Filtration Rate (eGFR), and Total Protein Excretion in 24hrs Urine sample and
Microalbuminuria were collected at initial level and after a period of treatment. The data were analyzed using suitable statistical
methods. Serum creatinine reduced with mean change of 0.1 % in ARB group and increased by 0.29% in ACEI group. With
respect to eGFR, ACEI and ARB groups show 0.08 % and 1.87 % improvement respectively. ARB shows 34.16% of mean
change in reduction of total protein excretion but in ACEI group it was only 4.38%. In Microalbuminuria, among the ACEI
group, the albumin remain stable from baseline to review in 84.38% of patients and reduced in 6.25% but in ARB group 40.79%
are stable and 51.32% shows reduction. All these three parameters viz. Serum creatinine , eGFR and Protein excretion, ACEI is
effective but ARB are more effective and shows significant changes especially in proteinuric patients. Treatment either with
ACEI or ARB at the earliest will be safe and cost benefit as it will delay the dialysis and transplantation which are more
expensive</Abstract><Email>siddhartha.pal8@gmail.com</Email><articletype>Research</articletype><volume>3</volume><issue>1</issue><year>2013</year><keyword>ACEI,ARB,Nephropathy,Proteinuria,Microalbuminuria</keyword><AUTHORS>S.Wasim Raja, Siddhartha Pal,A.M.Ismail, R.Senthamarai</AUTHORS><afflication>Dept. of Pharmacy Practice, Sri Venkateswara College of Pharmacy, RVS Nagar, Chittoor (AP), India,Dept. of Pharmacy Practice, Periyar College of Pharmaceutical Sciences, Trichy (TN), India,Dept. of Pharmacy Practice, Periyar College of Pharmaceutical Sciences, Trichy (TN), India,Dept. of Pharmacognosy, Periyar College of Pharmaceutical Sciences, Trichy (TN), India</afflication></Article></Articles>